An evaluation of a medication management training programme for community mental health professionals; service user level outcomes. A cluster randomised controlled trial

International Journal of Nursing Studies

Volumn 46, Issue 5, 2009, Pages 645-652

  Harris, Neil ^a   Lovell, Karina ^a   Day, Jennifer ^b   Roberts, Christopher ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b 5 Boroughs Partnership NHS Trust   (United Kingdom)

Author keywords

Antipsychotic; Education; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MANPOWER; MENTAL DISEASE; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL;

ANTIPSYCHOTIC AGENTS; CLUSTER ANALYSIS; COMMUNITY MENTAL HEALTH SERVICES; HUMANS; MENTAL DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 62749167610     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2008.10.010     Document Type: Article

References (28)

1. Baldessarini R.J., and Viguera A.C. Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry 52 (1995) 189-192
2. Birchwood M., Smith J., Cochrane R., Wetton S., and Copestake S. The social functioning scale the development and validation of a scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry 157 (1990) 853-859
3. Bland J., and Kerry S. Trials randomised in clusters. British Medical Journal 315 (1997) 600
4. Davison A.C., and Hinkley D.V. Bootstrap Methods and Their Application (1997), Cambridge University Press
5. Day J.C., Bentall R.P., Roberts C., Randall F., Rogers A., Cattell D., Healy D., Rae P., and Power C. Attitude toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Archives of General Psychiatry 62 (2005) 717-724
6. Day J.C., Wood G., Dewey M., et al. A self-rating scale for measuring neuroleptic side-effects: validation in a group of schizophrenic patients. British Journal of Psychiatry 166 (1995) 650-653
7. Department of Health, 2005. Improving mental health services by extending the role of nurses by prescribing and supplying medication; a good practice guide Pub DoH.
8. Department of Health, 2006. From values to action: the chief nursing officer's review of mental health nursing Pub DoH.
9. Donner A., and Klar. Design and Analysis of Cluster Randomisation Trial in Health Research (2000), Arnold
10. Donner A., Birkett N., and Buck C. Randomization by cluster: sample size requirements and analyses. American Journal of Epidemiology 114 (1981) 906-913
11. Gaston L., Marmar C., 1993. Manual of California Psychotherapy Alliance Scale.
12. Gilbert P.L., Harris M.J., McAdams L.A., and Jeste D.V. Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry 95 (1995) 173-188
13. Grey R., Wykes T., Edmonds M., Leese M., and Gournay K. Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia. British Journal of Psychiatry 185 (2004) 157-162
14. Gray R., Leese M., Bindman J., et al. Adherence therapy for people with schizophrenia European multicentre randomised controlled trial. British Journal of Psychiatry 189 (2006) 508-514
15. Harris N., Lovell K., and Day J.C. Mental Health practitioners attitude towards maintenance neuroleptic treatment for people with schizophrenia. Journal of Psychiatric and Mental health Nursing 14 (2007) 113-119
16. Hogan T.P., and Awad A.G. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine 13 (1983) 177-183
17. Kemp R., Heywood P., and David A. Compliance Therapy Manual (1997), NHS Trust, London Bethlem and Maudsley
18. Kemp R., David A., and Hayward P. Compliance therapy: an intervention targeting insight and treatment adherence in psychotic patients. Behavioural and Cognitive Psychotherapy 24 (1998) 331-350
19. Krawiecka M., Goldberg D., and Vaughan M. A standardised psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinvica 55 (1977) 299-308 modified by S. Lancashire (1998)
20. McIntosh, A.M., Conlon, L., Lawie, S.M., Stanfield, A.C., 2006. Compliance therapy for schizophrenia Cochrane Database of Systematic Reviews, 3.
21. Randell F., Wood P., Day J.C., Bentall R., Rogers A., and Healy D. Enhancing appropriate adherence with neuroleptic medication: two contrasting approaches. In: Morrison A.P. (Ed). A Case Book of Cognitive Therapy for Psychosis (2003), Brunner-Routledge
22. Roberts C. The implications of variation in outcome between health professionals for the design and analysis of randomized controlled trials. Statistics in Medicine 18 (1999) 2605-2615
23. Robinson D., Woerner M.G., Alvir J.M., et al. Predictors of relapse following response from a first episode of schizophrenia or schizo-affective disorder. Archives of General Psychiatry 56 (1999) 241-247
24. Sainsbury Centre for Mental Health, 2001. The Capable Practitioner; A framework and list of the practitioner capabilities required to implement, The National Service Framework for Mental Health Pub Sainsbury Centre for Mental Health.
25. Skingsley D., Bradley E.J., and Nolan P. Neuropharmacology and mental health nurse prescribers. Journal of Clinical Nursing 15 8 (2006) 989-997
26. Stata Statistical Software Release 8.0. Stata Statistical Software Release 8.0 (2002), Stata Corp College Station, Texas USA
27. Torgerson D.J. Contamination in trials: is cluster randomisation the answer?. British Medical Journal 322 (2001) 355-357
28. Ukoumunne O.C., Gulliford M.C., Chinn S., et al. Methods for evaluating area-wide and organisation-based interventions in health and health care: systematic review. Health Technology Assessment 3 (1999) 5